Your browser doesn't support javascript.
loading
Cross-national health care database utilization between Spain and France: results from the EPICHRONIC study assessing the prevalence of type 2 diabetes mellitus.
Moulis, Guillaume; Ibañez, Berta; Palmaro, Aurore; Aizpuru, Felipe; Millan, Eduardo; Lapeyre-Mestre, Maryse; Sailler, Laurent; Cambra, Koldo.
Afiliación
  • Moulis G; Department of Internal Medicine, Toulouse University Hospital, Toulouse, France, moulis.g@chu-toulouse.fr.
  • Ibañez B; UMR1027 INSERM, University of Toulouse, Toulouse, France, moulis.g@chu-toulouse.fr.
  • Palmaro A; Clinical Investigation Center 1436, Toulouse University Hospital, Toulouse, France, moulis.g@chu-toulouse.fr.
  • Aizpuru F; Navarrabiomed, Health Department, Public University of Navarra, Pamplona, Spain.
  • Millan E; IdiSNA, Pamplona, Spain.
  • Lapeyre-Mestre M; Health Service Research on Chronic Patients Network (REDISSEC), Pamplona, Spain.
  • Sailler L; UMR1027 INSERM, University of Toulouse, Toulouse, France, moulis.g@chu-toulouse.fr.
  • Cambra K; Clinical Investigation Center 1436, Toulouse University Hospital, Toulouse, France, moulis.g@chu-toulouse.fr.
Clin Epidemiol ; 10: 863-874, 2018.
Article en En | MEDLINE | ID: mdl-30100760
ABSTRACT

AIM:

The EPICHRONIC (EPIdemiology of CHRONIC diseases) project investigated the possibility of developing common procedures for French and Spanish electronic health care databases to enable large-scale pharmacoepidemiological studies on chronic diseases. A feasibility study assessed the prevalence of type 2 diabetes mellitus (T2DM) in Navarre and the Basque Country (Spain) and the Midi-Pyrénées region (France). PATIENTS AND

METHODS:

We described and compared database structures and the availability of hospital, outpatient, and drug-dispensing data from 5.9 million inhabitants. Due to differences in database structures and recorded data, we could not develop a common procedure to estimate T2DM prevalence, but identified an algorithm specific to each database. Patients were identified using primary care diagnosis codes previously validated in Spanish databases and a combination of primary care diagnosis codes, hospital diagnosis codes, and data on exposure to oral antidiabetic drugs from the French database.

RESULTS:

Spanish and French databases (the latter termed Système National d'Information Inter-Régimes de l'Assurance Maladie [SNIIRAM]) included demographic, primary care diagnoses, hospital diagnoses, and outpatient drug-dispensing data. Diagnoses were encoded using the International Classification of Primary Care (version 2) and the International Classification of Diseases, version 9 and version 10 (ICD-9 and ICD-10) in the Spanish databases, whereas the SNIIRAM contained ICD-10 codes. All data were anonymized before transferring to researchers. T2DM prevalence in the population over 20 years was estimated to be 6.6-7.0% in the Spanish regions and 6.3% in the Midi-Pyrénées region with ~2% higher estimates for males in the three regions.

CONCLUSION:

Tailored procedures can be designed to estimate the prevalence of T2DM in population-based studies from Spanish and French electronic health care records.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prevalence_studies / Risk_factors_studies Aspecto: Implementation_research Idioma: En Revista: Clin Epidemiol Año: 2018 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prevalence_studies / Risk_factors_studies Aspecto: Implementation_research Idioma: En Revista: Clin Epidemiol Año: 2018 Tipo del documento: Article
...